A novel, multi-analyte test developed by researchers at the Johns Hopkins Kimmel Cancer Center, its Ludwig Center and the Johns Hopkins Department of Neurosurgery can accurately identify brain cancers using small samples of cerebrospinal fluid (CSF), offering a promising new tool to guide clinical decision-making.
Treatment with exagamglogene autotemcel (exa-cel) led to robust and sustained improvements in quality of life for patients with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia, according to two studies published in Blood Advances.
Scientists at Kumamoto University have made a major breakthrough in regenerative medicine by successfully creating functional ureter tissue—organoids resembling the urinary tract—from pluripotent stem cells.
The eye, like most organs, has an intricate plumbing system. Pressure builds when drainage is impaired, and this condition—glaucoma—can cause irreversible vision loss. Certain popular anti-inflammatory eye medications that contain steroids can in some cases compound the problem, although scientists have been at a loss to understand why.
A newly designed backpack, incorporating aerospace technology, shows promise as a balance aid for patients with the movement disorder ataxia. Research conducted by Radboud university medical center, in collaboration with Delft University of Technology (TU Delft) and Erasmus MC, reveals that the backpack helps individuals with ataxia stand and walk more steadily, reducing their reliance on mobility aids like walkers.
An AI tool could help cardiologists identify and target cells that trigger arrhythmia in patients with ventricular tachycardia, a serious heart condition.
Researchers at National Taiwan University developed a biodegradable, electroconductive self-healing hydrogel combined with acupuncture that restores motor function and protects brain neurons in Parkinson’s disease models.
Researchers at Baylor College of Medicine have developed an artificial intelligence (AI) model that reveals how protein modifications link genetic mutations to disease. The method, called DeepMVP and published in Nature Methods, significantly outperforms previously published models and has implications for the development of novel therapeutics.
Researchers have developed a new light technology that appears to improve cognitive function in Alzheimer’s patients in clinical trials. The hope is that the idea can be developed into ordinary lamps that people can install to prevent the disease.
Messenger RNA, or mRNA, vaccines entered the public consciousness when they were introduced during the COVID-19 pandemic, and both Pfizer-BioNTech and Moderna used the technology in developing their highly effective vaccines to fight the virus.